Hooker, Jonathan C.
Hamilton, Gavin
Park, Charlie C.
Liao, Steven
Wolfson, Tanya
Dehkordy, Soudabeh Fazeli
Hong, Cheng William
Mamidipalli, Adrija
Gamst, Anthony
Loomba, Rohit
Sirlin, Claude B.
Funding for this research was provided by:
Merck (K23-DK090303)
National Institutes of Health (R01 DK083380-01, T32EB005970)
Article History
First Online: 20 August 2018
Compliance with ethical standards
:
: The project described was partially supported by the National Institutes of Health Grants K23-DK090303, R01 DK083380-01, and T32EB005970. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
: Jonathan C. Hooker, Dr. Gavin Hamilton, Charlie C. Park, Dr. Steven Liao, Tanya Wolfson, Dr. Soudabeh Fazeli Dehkordy, Dr. Cheng William Hong, Dr. Adrija Mamidipalli, and Dr. Anthony Gamst declare that they have no conflict of interest. Dr. Rohit Loomba has the following disclosure related to this study: Daiichi-Sankyo. Dr. Claude B. Sirlin has the following disclosures not related to this study. Industry service agreements and consultation agreements: Alexion, AstraZeneca, Bioclinica, BMS, Fibrogen, Galmed, Genzyme, Gilead, Fibrogen, Icon, Intercept, Isis, Janssen, NuSirt, Perspectum, Pfizer, Profil, Sanofi, Shire, Synageva, Tobira, Takeda, VirtualScopics.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional and/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.